Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

RNA US Equity

Atrium Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 2093101 · FY ends Dec 31
$13.71
+0.87 (+6.78%)
USD · as of 2026-08-19 · marketstack
5 8-K filings · 0 13D · 7 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Sessa Capital IM, L.P.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by PRICE T ROWE ASSOCIATES INC /MD/sec.gov ↗
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-07-148-K 8.01Other eventssec.gov ↗
2026-05-1513GSchedule 13G filed — ≥5% beneficial owner (passive) · by RA CAPITAL MANAGEMENT, L.P.sec.gov ↗
2026-05-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
2026-04-0813GSchedule 13G filed — ≥5% beneficial owner (passive) · by PRICE T ROWE ASSOCIATES INC /MD/sec.gov ↗
2026-02-278-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-02-278-K 5.01Changes in control of registrantsec.gov ↗
2026-02-278-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-02-268-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-02-26

Every row is a filed document, checked against its EDGAR index.